<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01579864</url>
  </required_header>
  <id_info>
    <org_study_id>2011/05</org_study_id>
    <secondary_id>2011-000370-59</secondary_id>
    <nct_id>NCT01579864</nct_id>
  </id_info>
  <brief_title>Succinylcholine or Rocuronium for Rigid Bronchoscopy Under General Anesthesia</brief_title>
  <acronym>Broncho-SR</acronym>
  <official_title>Interventional Rigid Bronchoscopy Under General Anesthesia: Influence of the Muscle Relaxant, Succinylcholine or Rocuronium, on the Quality of the Surgical Procedure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Myorelaxation is generally used as a part of general anesthesia for interventional rigid
      bronchoscopy. Succinylcholine is most often used because its short duration of action but
      rocuronium can be used since sugammadex permits a rapid and complete reversal of the
      neuromuscular block. The aim of ths study is to compare both agents.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    recent publication (Ghezel-Ahmadi. Thorac Cardiovasc Surg. 2014 Nov 21)
  </why_stopped>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Score of quality of the surgical procedure</measure>
    <time_frame>one day</time_frame>
    <description>The quality of the surgical procedure is evaluated by the surgeon (composite score) who is unaware of the neuromuscular agent used (see Fuchs-Buder et al. Acta Anaesthesiol Scand 2007;51(7):789-808)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Score of quality of anesthesia</measure>
    <time_frame>one day</time_frame>
    <description>The quality of anesthesia is evaluated by the anesthesist in charge on a scale 0-30 (0-10 for the induction ; 0-10 for maintenance; 0-10 for recovery)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>succinylcholine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Succinylcholine 1 mg/kg and a second dose if necessary.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rocuronium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>rocuronium 0,9 mg/kg with additional boluses of 0,3 mg/kg f necessary</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>succinylcholine</intervention_name>
    <description>Succinylcholine 1 mg/kg and a second dose if necessary. Rocuronium 0,4 mg/kg can be used as a rescue</description>
    <arm_group_label>succinylcholine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>rocuronium</intervention_name>
    <description>rocuronium 0,9 mg/kg with additional boluses of 0,3 mg/kg f necessary</description>
    <arm_group_label>Rocuronium</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients scheduled for an interventional rigid bronchoscopy under general anesthesia

        Exclusion Criteria:

          -  pregnant woman or woman of childbearing age,

          -  morbid obesity,

          -  drug allergy,contra-indication to succinylcholine, rocuronium, sugammadex, propofol,
             remifentanil,

          -  history of central neurological or brain damage,

          -  psychotropic treatment,

          -  pacemaker,

          -  renal failure,

          -  disease of the neuromuscular junction.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Morgan Le Guen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital Foch</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital Foch</name>
      <address>
        <city>Suresnes</city>
        <state>Ile de France</state>
        <zip>92151</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 4, 2012</study_first_submitted>
  <study_first_submitted_qc>April 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2012</study_first_posted>
  <last_update_submitted>November 2, 2016</last_update_submitted>
  <last_update_submitted_qc>November 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rocuronium</mesh_term>
    <mesh_term>Succinylcholine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

